Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Partnership to Advance 3D Osteoporosis Assessment

By MedImaging staff writers
Posted on 23 Jun 2006
Hologic, Inc. More...
(Bedford, MA, USA) has reached a strategic research agreement with Prof. Klaus Engelke, Ph.D., head of the Osteoporosis Research Center of the Institute of Medical Physics, University of Erlangen-Nürnberg (Germany). Under the terms of this agreement, Prof. Engelke will provide computed tomography (CT) datasets with segmented femurs for use in the development of volumetric reference data on the Hologic QDR (quantitative digital radiography) Discovery system.

"Clinicians have long sought the next generation of osteoporosis assessment tools to better predict femur fracture risk,” commented Brad Herrington, Hologic vice president of Skeletal Health Imaging. "We believe that the research of Prof. Engelke and his colleague Willi A. Kalender will help bring us closer to the commercialization of a low-dose tomographic assessment of bone density and geometry to discern bone structure and strength.”

"Hologic has realized the importance of 3D [three-dimensional] femur analysis to the measurement of bone strength,” said Prof. Engelke. "Clinical and research applications with CT so far have been limited by the high radiation dose necessary and the difficulty in accurate and reproducible segmentation of bone from soft tissue. While we have solved the 3D segmentation problem, a lower dose method of determining the three dimensional structure of the femur would have a definite attraction to the researcher and clinician alike.”

"Our hope is that tomographic 3D analysis will ultimately be available on all Discovery systems with rotational C-arm capability,” Mr. Herrington noted. "The exclusive rotating C-arm capability of Discovery affords maximized patient comfort and efficient workflow by allowing the patient to remain in a comfortable supine position for the entire range of bone density procedures including instant vertebral assessment.”



Related Links:
Hologic
University of Erlangen-Nürnberg

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.